q12023-utilization-management-updates-1.1.23.pdf
Documents & Forms Results
Displaying 841 - 850 of 3680 results
Provider
QP101-22 Update for New to Market Medical Drugs: Lecanemab and Lifileucel
Program effective Date: Dec 16, 2022
Provider
QP108-22 MHCP Pharmacy Benefit Exclusion-Xolair
Program effective Date: Dec 14, 2022
Provider
QP107-22 PCA Agency Requirements
Program effective Date: Dec 14, 2022
Provider
QP104-22 Fee Schedule Requests Only Accepted from Contracted Providers
Program effective Date: Dec 14, 2022
Provider
QP106-22 MHCP Pharmacy Benefit Exclusion Floxuridine
Program effective Date: Dec 14, 2022
Provider
QP109-22 New Provider Toolkit
Program effective Date: Dec 14, 2022
Provider
QP105-22 Provider Press Year-End 2022
Program effective Date: Dec 14, 2022
Provider
QP103-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective February 1, 2023
Program effective Date: Dec 14, 2022
Provider
QP 102-22 MHCP Pharmacy Benefit Exclusion for Imjudo® and Tecvayli™
Program effective Date: Dec 14, 2022